- Previous Close
43.09 - Open
44.99 - Bid --
- Ask 45.06 x --
- Day's Range
42.82 - 51.00 - 52 Week Range
40.40 - 91.87 - Volume
430,976 - Avg. Volume
32,228 - Market Cap (intraday)
723.1M - Beta (5Y Monthly) 2.02
- PE Ratio (TTM)
116.11 - EPS (TTM)
0.38 - Earnings Date Feb 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Biofil Chemicals and Pharmaceuticals Limited manufactures and trades in pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic drippers and caps for packing applications. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.
www.biofilgroup.net26
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BIOFILCHEM.NS
View MorePerformance Overview: BIOFILCHEM.NS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIOFILCHEM.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIOFILCHEM.NS
View MoreValuation Measures
Market Cap
738.51M
Enterprise Value
740.85M
Trailing P/E
118.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.81
Price/Book (mrq)
3.99
Enterprise Value/Revenue
1.84
Enterprise Value/EBITDA
62.84
Financial Highlights
Profitability and Income Statement
Profit Margin
1.49%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
406.12M
Net Income Avi to Common (ttm)
6.07M
Diluted EPS (ttm)
0.38
Balance Sheet and Cash Flow
Total Cash (mrq)
2.2M
Total Debt/Equity (mrq)
2.47%
Levered Free Cash Flow (ttm)
--